SEC Filing Summary: ChromaDex Corporation (CDXC)
Business Context and Reporting Period
This Form 8-K was filed by ChromaDex Corporation on November 8, 2023. The filing serves to announce the Company's earnings results for the quarter ended September 30, 2023, and to disclose a corporate investor presentation made available on the Company's website. The registrant is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol CDXC.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are not included in the source text provided.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of the Q3 2023 earnings announcement.
Guidance, Outlook, and Risks
The filing references a corporate presentation (Exhibit 99.2) which typically contains management commentary, outlook, and risk factors, but the text of the presentation is not included in this document. The filing explicitly states that the information furnished in Items 2.02 and 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2023 revenue, net income, and cash flow figures.
- Examine Exhibit 99.2 (Investor Presentation) for management's guidance, strategic outlook, and discussion of risks.
- Verify the Company's liquidity position and debt obligations in the full earnings release, as these are not stated in the 8-K cover text.
- Confirm the trading status of CDXC on the Nasdaq Capital Market following the earnings announcement.